ManyPets

ManyPets (formerly Bought By Many) is a London-based pet insurance MGA and carrier group founded in 2012 by CEO Steven Mendel (a former McKinsey actuary) and CTO Guy Farley. The original thesis was group-buying-as-distribution: aggregating consumer demand in niche insurance segments (cancer, travel, gadget) and using that collective leverage to negotiate better terms from carriers. By 2017 the team had pivoted away from multi-segment group-buying and concentrated the entire business on direct-to-consumer pet medical insurance, initially as an MGA on Great Lakes Insurance SE (a Munich Re subsidiary) paper. The company rebranded from Bought By Many to ManyPets globally in 2021 — Sweden first in November 2020, the US at launch in March 2021, and the UK in 2022 — at which point the holding company became Many Group Ltd.

Capital formation. ManyPets has raised approximately $483M of disclosed equity across its Seed, Series A/B/C/D rounds. The capstone round is the June 1, 2021 $350M Series D led by EQT Growth with Willoughby Capital, alongside follow-on from FTV Capital, Octopus Ventures, CommerzVentures, and Munich Re Ventures — pricing the company at a $2.0-2.4B valuation and making it one of the largest insurtech investments in European history at the time. The prior Series C, announced May 4, 2020, was a £78.4M (~$97.6M) growth round led by FTV Capital with the same existing-investor syndicate. Earlier, a July 2018 Series B of £20M was led by CommerzVentures. The original ask of ~$540M total funding could not be corroborated against primary sources; Sifted's 2024 accounting reporting, Crunchbase, and CommerzVentures converge on ~$483M of disclosed equity, which is the figure used here.

Carrier stack. ManyPets has run a two-region carrier structure. In the UK, ManyPets operates as an FCA-regulated MGA; from inception through 2022 its UK paper was Great Lakes Insurance SE (a Munich Re specialty subsidiary), and from January 2023 onward it is Wakam — the European B2B2C white-label carrier (formerly La Parisienne Assurances) that uses its Play&Plug platform to underwrite more than 150 distribution partners across 32 countries. In the US, ManyPets launched in March 2021 as an MGA on Accredited Surety and Casualty Company paper, and on October 25, 2022 acquired Digital Edge Insurance Company from Munich Re Digital Partners US Holding Corporation, renaming it Many Insurance Company. That acquisition gave ManyPets its own admitted US carrier in up to 45 states. The US carrier was sold to an undisclosed third party for £22M in November 2024 as ManyPets exited the US market, with existing US customers transitioned to Odie Pet Insurance effective January 1, 2025.

AI product stack: Millie, Akur8, Vet-AI. ManyPets markets three distinct AI-driven technology layers. Millie, its internally-built claims automation assistant, processed approximately 45% of UK claims end-to-end during FY2024/25, with many settled within 24 hours of submission via automated validation against policy terms and vet invoice parsing. Pricing and rating uses Akur8's machine-learning GLM platform — the February 2022 ManyPets-Akur8 partnership publicly announced via Business Wire is one of Akur8's reference deployments. Customer-side telemedicine is powered by the April 2026 Vet-AI partnership (ManyPets members get included access to AI-triaged video consultations with licensed vets through the Vet-AI/FirstVet platform). The combined pitch — automated claims, ML pricing, embedded telemedicine — is the AI-native differentiator relative to legacy UK pet insurers (Petplan/Allianz, Animal Friends) that remain on reimbursement-only workflows.

Positioning vs Trupanion. Trupanion (NASDAQ: TRUP, founded 2000) is the defensive monoline benchmark: it owns a patented direct-pay integration with veterinary practice management systems (Trupanion Express / VetDirect Pay) that settles claims with the hospital at time of checkout, in seconds, across the US, Canada, Australia, and Puerto Rico. ManyPets has no equivalent vet-direct-pay software asset in the UK market — its claims moat is post-visit reimbursement turnaround speed via Millie, not point-of-care settlement rails inside the vet workflow. The two companies represent opposing bets on where pet-insurance durability is built: Trupanion inside the veterinary PMS, ManyPets inside the consumer digital experience.

Positioning vs Lemonade Pet. Lemonade (NYSE: LMND, founded 2015) sells pet as one SKU inside a multi-line AI-native carrier (renters, homeowners, pet, life, auto), with explicit LTV economics driven by cross-sell (pet + renters + auto bundled into a single Maya/AI Jim experience). ManyPets is monoline by design — cats and dogs only, no bundling opportunity, no renters or auto distribution. The tradeoff is commercial focus versus lifetime-value ceiling: ManyPets can invest every engineering cycle on pet-specific pricing and claims automation (Akur8 GLMs trained on pet data, Millie trained on pet vet invoices), but it cannot offset pet customer acquisition cost against a second or third line the way Lemonade can. The US exit in 2024 was effectively the confirmation that monoline pet unit economics did not work in a market where Lemonade, Trupanion, MetLife Pet, Embrace, Healthy Paws, and Nationwide were all competing for the same digital-first pet owner.

Financials and the 2025 inflection. FY2024/25 (year ending 31 March 2025) was ManyPets' first profitable fiscal year since launching pet insurance in 2017: net profit of £6.25M on revenue of £62M and UK gross written premium of £232M, versus a £33M loss on £29.6M of revenue the prior year. The loss ratio fell from 78% to 70%, attributed by management to tighter pricing, book clean-up, and the exit from loss-making geographies (Sweden in 2023, US in late 2024). Over the two-year period FY2022/23-FY2024/25 ManyPets reduced its annual loss from £67.5M to zero-plus while the employee base shrank substantially (~100 roles cut in summer 2023 per Sifted reporting).

Market positioning and gaps. ManyPets does not appear in Gartner, Forrester, or Celent evaluations of core underwriting or claims platforms — pet insurance is not a category these analysts formally cover. Recognition is concentrated in European technology press (Sifted's ongoing coverage of the unicorn's retrenchment, Tech.eu, TechCrunch's pet-insurance sector coverage), UK insurance trade press (Insurance Times, Insurance Post, Insurance Business UK, The Insurer), and press around two strategic events: the June 2021 EQT-led $350M Series D, and the November 2024 US market exit. The combination — AI-native digital pet insurer, UK monoline, profitable 2025, post-unicorn retrenchment — makes ManyPets the clearest European analog to the US AI-native pet-insurance thesis, and a useful counterpoint to both Trupanion (veterinary-hospital infrastructure moat) and Lemonade Pet (multi-line bundling moat).